Among women with BARD1 mutations one study appeared to show an increased ovarian cancer risk (OR 4.2 95% CI 1.4-12.5) compared to population estimates from large, publicly available exome sequencing datasets [10]. This evidence concerns the gene BARD1 and ovarian cancer.